Display options
Cite
Huang D, Tang L, Yang F, et al. . Am J Transl Res. 2019;11(9):6055-6065
Huang, D., Tang, L., Yang, F., Jin, J., & Guan, X. (2019). . American journal of translational research, 11(9), 6055-6065.
Huang, Doudou, et al. "." American journal of translational research vol. 11,9 (2019): 6055-6065.
Huang D, Tang L, Yang F, Jin J, Guan X. . Am J Transl Res. 2019 Sep 15;11(9):6055-6065. eCollection 2019. PMID: 31632573; PMCID: PMC6789267.
Copy Download .nbib Format: NLM
Share it on

Am J Transl Res. 2019 Sep 15;11(9):6055-6065. eCollection 2019.

[No title available]

American journal of translational research

Doudou Huang, Lin Tang, Fang Yang, Juan Jin, Xiaoxiang Guan

Affiliations

  1. Department of Medical Oncology, Jinling Hospital, Medical School of Nanjing University Nanjing 210002, China.
  2. Department of Oncology, The First Affiliated Hospital of Nanjing Medical University Nanjing 210029, China.

PMID: 31632573 PMCID: PMC6789267

Abstract

p110α is an important subunit of phosphatidylinositol-3-kinases (PI3Ks) encoded by

AJTR Copyright © 2019.

Keywords: Fulvestrant resistance; PIK3CA mutation; estrogen receptor-positive breast cancer

Conflict of interest statement

None.

References

  1. Nat Rev Drug Discov. 2009 Aug;8(8):627-44 - PubMed
  2. Biochim Biophys Acta Rev Cancer. 2017 Aug;1868(1):148-156 - PubMed
  3. Mol Cancer Ther. 2011 Nov;10(11):2016 - PubMed
  4. N Engl J Med. 2015 Oct 22;373(17):1672-3 - PubMed
  5. Cancer Cell. 2009 Aug 4;16(2):115-25 - PubMed
  6. JAMA Oncol. 2016 Dec 1;2(12):1565-1573 - PubMed
  7. Proc Natl Acad Sci U S A. 2013 Apr 16;110(16):E1490-9 - PubMed
  8. CA Cancer J Clin. 2018 Jan;68(1):7-30 - PubMed
  9. Ann Oncol. 2012 Sep;23(9):2399-408 - PubMed
  10. Oncologist. 2006 Jul-Aug;11(7):704-17 - PubMed
  11. Nature. 2000 Aug 17;406(6797):747-52 - PubMed
  12. Annu Rev Med. 2011;62:217-32 - PubMed
  13. Annu Rev Med. 2011;62:233-47 - PubMed
  14. Clin Cancer Res. 2017 Sep 1;23(17):5218-5224 - PubMed
  15. J Natl Cancer Inst. 2011 Mar 16;103(6):451-3 - PubMed
  16. Proc Natl Acad Sci U S A. 2008 Feb 19;105(7):2652-7 - PubMed
  17. Sci Transl Med. 2014 Feb 19;6(224):224ra24 - PubMed
  18. Invest New Drugs. 2014 Aug;32(4):670-81 - PubMed
  19. Cell. 1995 Jun 2;81(5):727-36 - PubMed
  20. Cancer Cell. 2014 Jul 14;26(1):136-49 - PubMed
  21. Lancet Oncol. 2016 Apr;17(4):425-439 - PubMed
  22. J Clin Oncol. 2018 May 1;36(13):1291-1299 - PubMed
  23. Nat Clin Pract Oncol. 2007 Jul;4(7):415-23 - PubMed
  24. Breast Cancer Res. 2011;13(6):224 - PubMed
  25. Lancet Oncol. 2016 Jun;17(6):811-821 - PubMed
  26. Nat Rev Cancer. 2015 May;15(5):261-75 - PubMed
  27. Nature. 1988 Apr 14;332(6165):644-6 - PubMed
  28. Cancer Res. 1991 Aug 1;51(15):3867-73 - PubMed
  29. Oncologist. 2017 Sep;22(9):1039-1048 - PubMed

Publication Types